Posted by Michael Wonder on 23 Apr 2019
PHARMAC reportedly has rejected funding for breast cancer drug
23 April 2019 - A breast cancer support group has been told that PHARMAC has rejected funding for the drug Kadcyla.
The health select committee considered a petition signed by 34,000 people earlier this month calling for the Government drug-buying agency to fully fund the drug.
The drug has been funded in Australia since 2015, but has been under consideration in New Zealand for some time.
